UÀÖ¹ú¼ÊÒ½Ò©¹ú¼ÊͨÓÃÊÖÒÕÒªÇóϵÄÒ©Æ·ÖÊÁ¿Ñо¿
·ÖÀࣺ
UÀÖ¹ú¼ÊÉú³¤Óª
Ðû²¼Ê±¼ä£º
2020-12-16
¡¡¡¡2018Äê4ÔÂ13ÈÕ£¬£¬£¬±±¾©UÀÖ¹ú¼ÊÒ½Ò©¿Æ¼¼¹É·ÝÓÐÏÞ¹«Ë¾Ï²ÓÃÀ¹úÈýºÍÒ©Òµ T3 PHARMA LINKÊ×´´È˼æ×ܲÃÌÀÀöÑŲ©Ê¿¡¢ÄϾ©°ØÏÍÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾×Ü˾ÀíФ°ØÃ÷²©Ê¿Ý°ÁÙÖ¸µ¼£¬£¬£¬²¢Î§ÈÆ¡°Ò©ÎïÖÊÁ¿¹æÔòICHÓëÆÊÎöÒªÁ족¼°¡°ÆÊÎöÒªÁìµÄÆðµã£¬£¬£¬Öյ㼰ÖÜÆÚÖÎÀí¡±µÈÒ©Æ·ÖÊÁ¿Ñо¿·½Ã濪չÁ˾«²ÊµÄѧÊõ±¨¸æ¡£¡£¡£¡£¡£¡£
¡¡¡¡ÎÒ¹«Ë¾¼á³Ö¡°ÒÔÊÖÒÕΪ½¹µã¡¢ÒÔÈ˲ÅΪ»ù´¡¡±µÄÖÎÆóÄ¿µÄ£¬£¬£¬ÔÚÒ½Ò©¿ÆÑÐÁìÓòÖÐһֱǿ»¯Ìá¸ßÑз¢Ö°Ô±µÄ¿ÆÑÐˮƽ£¬£¬£¬´Ë´ÎѧÊõ±¨¸æÒ²Îª¹«Ë¾µÄ»¯Ñ§Ò©ÎïÑз¢ÊÂÇé×¢ÈëÁËÏȽøµÄÑз¢Ë¼Ð÷£¬£¬£¬²¢Í¨¹ý¹«Ë¾ÏîÄ¿µÄ°¸ÀýÆÊÎöÉîÈëdz³öµÄ½«Ò©ÎïÑз¢µÄÀíÂÛÓëʵ¼ù¾ÙÐÐÁËÍêÉÆµÄÁ¬Ïµ¡£¡£¡£¡£¡£¡£
¡¡¡¡ÌÀÀöÑŲ©Ê¿ÔÚ´Ë´ÎÅàѵÖУ¬£¬£¬Õë¶ÔÒ©ÎïÖÊÁ¿¹æÔòICH·½Ã棺¶ÔÒ©ÎïÆÊÎöÒªÁìÓÈÆäÊDzî±ðÑз¢½×¶ÎµÄÆÊÎöÒªÁìµÄ¹æ·¶¼°ºÏÀíÐÔ×ö³öÖ¸µ¼;³ýÒ©µä±ê×¼¡¢CFDAÐû²¼¸÷Ò©ÎïÑз¢Ö¸µ¼ÔÔòÍ⣬£¬£¬Õë¶ÔÖÖÖÖÔÓÖʵĿØÖÆÒªÁì¼°ÒªÇ󣬣¬£¬Èç»ùÒò¶¾ÐÔÔÓÖÊ¡¢Òì¹¹/ÊÖÐÔ¼°²ÐÁôÈܼÁµÈ¡£¡£¡£¡£¡£¡£ÆÊÎöÒªÁìµÄÆðµã¡¢Öյ㼰ÖÜÆÚÖÎÀí·½Ãæ£º°üÀ¨ÆÊÎöÒªÁìµÄÖÊÁ¿Ô´ÓÚÉè¼Æ£¬£¬£¬ÒªÁìµÄÄ¿µÄ£¬£¬£¬·çÏÕÆÀ¹À;ÆÊÎöÒªÁìµÄÑéÖ¤¡¢È·Èϼ°×ªÒƵȡ£¡£¡£¡£¡£¡£¾ÓÉ´Ë´ÎϵͳµÄ½â˵Åàѵ£¬£¬£¬ÏàÐÅÒÔºóͬÊÂÃÇÆÊÎöÒªÁ쿪·¢Àú³ÌÖеÄ˼Ð÷½«»á¸üÃ÷Îú¡£¡£¡£¡£¡£¡£
¡¡¡¡ÌÀ²©Ê¿ºÜÏêϸµÄ¶ÔICHQ8¡¢Q9¡¢Q10¾ÙÐÐÏàʶ˵£¬£¬£¬¹ØÓÚÒ©Æ·Ñз¢£¬£¬£¬ÒÑÍù¹Ø×¢µÄÊÇÊý¾Ýת´ï¡¢¿É±äµÄÊä³öÁ¿£¬£¬£¬¶øÏÖÔÚ¸ü¹Ø×¢ÖªÊ¶×ª´ïºÍ»ùÓÚ¿ÆÑ§/Ò»ÖµÄÊä³öÁ¿;ÖÊÁ¿·çÏÕÖÎÀí£¬£¬£¬ÒÑÍùȱ·¦½ç˵£¬£¬£¬·Ç½á¹¹»¯£¬£¬£¬¶øÏÖÔÚʹÓýṹ»¯Á÷³Ì;Q10Ò©Æ·ÖÊÁ¿ÏµÍ³£¬£¬£¬ÌáÐÑÎÒÃÇÔÚδÀ´£¬£¬£¬Ó¦½¨Éè¹á´®²úÆ·ÉúÃüÖÜÆÚµÄÖÊÁ¿ÏµÍ³£¬£¬£¬ÇÒÕû¸öÉúÃüÖÜÆÚÖÊÁ¿ÏµÍ³Òª¼á³ÖÒ»ÖÂÐÔ;Q12Ö¸µ¼ÆóÒµ£¬£¬£¬ÔÚ²Ù×÷¹æ³ÌÖÐÓ¦ÔöÌíÁè¼Ý»®¶¨ÏÞ¶ÈÖ®ÍâµÄÇéÐÎÏ£¬£¬£¬ÔõÑù²Ù×÷ºÍ´¦Àí£¬£¬£¬ÒÔïÔÌÉÏÊкó±ä»»µÄÖØ´óÐÔ£¬£¬£¬ÎªUÀÖ¹ú¼ÊÑз¢ÊÂÇéÌṩÁËеÄ˼Ð÷¡£¡£¡£¡£¡£¡£
¡¡¡¡¹ØÓÚ»ùÒò¶¾ÐÔÔÓÖÊ£¬£¬£¬ICH M7ÓÐÏêϸµÄ»ùÒò¶¾ÐÔÔÓÖÊ·ÖÀ࣬£¬£¬¸Å¿öÆðÀ´´óÖ·ÖΪÒÔϼ¸ÖÖ£º
Impurity Class ÔÓÖÊÖÖ±ð |
Definition ½ç˵ |
Guidance for control ¿ØÖÆÖ¸µ¼ |
Class 1 |
Known mutagenic carcinogens ÒÑÖªÖÂÍ»±äÖ°©Îï |
Control at or below compoundspecific acceptable limit ¿ØÖÆÔÚ»¯ºÏÎïÌØÒìÐÔµÄÌØ½ÓÊÜÏÞ¶ÈÒÔÏ |
Class 2 |
Known mutagens with unknown carcinogenic potential (bacterial mutagenicity positive*, no rodent carcinogenicity data) Ö°©ÐÔδ֪µÄÒÑÖªÖÂÍ»±äÎϸ¾úÖÂÍ»±äÐÔÑôÐÔ*£¬£¬£¬ÎÞÄö³Ý¶¯ÎïÖ°©ÐÔÊý¾Ý£© |
Control at or below acceptable limits (appropriate TTC) ¿ØÖÆÔڿɽÓÊÜÏÞ¶È£¨ºÏÊʵÄTTC£©ÒÔÏ |
Class 3 |
Alerting structure, unrelated to the structure of the drug substance; no mutagenicity data ¾¯Ê¾½á¹¹£¬£¬£¬ÓëÖÊÁÏÒ©½á¹¹Î޹أ»£»£»ÎÞÖÂÍ»±äÐÔÊý¾Ý |
If non-mutagenic = Class 5 ÈçÎÞÖÂÍ»±äÐÔ£¬£¬£¬¹éΪ5Àà If mutagenic = Class 2 ÈôÓÐÖÂÍ»±äÐÔ£¬£¬£¬¹éΪ2Àà |
Class 4 |
Alerting structure, same alert in drug substance or compounds related to the drug substance ¾¯Ê¾½á¹¹£¬£¬£¬ÓëÖÊÁÏÒ©½á¹¹Óйأ»£»£»ÎÞÖÂÍ»±äÐÔÊý¾Ý |
Q3A Q3B
|
Class 5 |
No structural alerts, or alerting structure with sufficient data to demonstrate lack of mutagenicity or carcinogenicity ÎÞ¾¯Ê¾½á¹¹ |
¡¡¡¡»ùÒò¶¾ÐÔÔÓÖÊÆÊÎöÖÐʹÓÃµÄÆÊÎöÊÖÒÕ£¬£¬£¬¹éÀàÆðÀ´ÓÐÒÔϼ¸ÖÖ£º
¡¡¡¡¹ØÓÚ´ó´ó¶¼Ò©ÎïµÄ»ùÒò¶¾ÐÔÔÓÖÊ£¬£¬£¬¿ÉÒÔÓÃLC-MS¼°GC-MSÀ´¾ÙÐмì²â£¬£¬£¬ÖÖÖÖÆÊÎöÊÖÒÕÒªÁìµÄʹÓðٷֱȼûÏÂ±í£º
¡¡¡¡¹ØÓÚÆÊÎöÒªÁìµÄÖÊÁ¿Ô´ÓÚÉè¼Æ£¬£¬£¬ÌÀ²©Ê¿¸üÊÇÓÐÒ»Ì××Ô¼ºÓÐÓõÄDOEÒªÁ죬£¬£¬¿ÉÒÔʹÓá°Óã¹Çͼ¡±»ò±í¸ñÐÎʽ£¬£¬£¬»®·ÖÆÊÎö¸÷²ÎÊýµÄ·çÏÕÒò×Ó£¬£¬£¬Æ¾Ö¤·çÏÕ¼¶±ðµÄ´óС£¡£¡£¡£¡£¡£¬£¬£¬È·¶¨ÆÊÎöÒªÁìÉè¼Æ¿Õ¼ä¡£¡£¡£¡£¡£¡£
Risk for Low or High Assay/Impurity Results£¨º¬Á¿/ÓйØÎïÖÊ·çÏÕÆÀ¹À±í£© | |||||
Risk Factor (Failure mode) |
Severity high=3 medium=2 low=1 |
Probability high=3 medium=2 low=1 |
Detectability high=1 medium=2 low=3 |
Numerical Rating S¡ÁP¡ÁD |
CQA |
Environment | ¡¡ | ¡¡ | ¡¡ | ¡¡ | ¡¡ |
Room Temperature | 1 | 1 | 1 | 1 | ¡¡ |
Room Humidity£¨regular samples£© | 1 | 2 | 1 | 2 | ¡¡ |
Room Humidity£¨hydroscopic samples£© | 3 | 2 | 1 | 6 | Y |
Material | ¡¡ | ¡¡ | ¡¡ | ¡¡ | ¡¡ |
sample | ¡¡ | ¡¡ | ¡¡ | ¡¡ | ¡¡ |
Solvent£¨more risk on impurity£© | 2 | 2 | 2 | 8 | Y |
Water£¨more risk on impurity£© | 2 | 2 | 2 | 8 | Y |
Analyst | ¡¡ | ¡¡ | ¡¡ | ¡¡ | ¡¡ |
Weighting | 3 | 2 | 2 | 12 | Y |
Mixing | 3 | 2 | 2 | 12 | Y |
Transferring | 3 | 2 | 2 | 12 | Y |
Glassware | ¡¡ | ¡¡ | ¡¡ | ¡¡ | ¡¡ |
Volumetric flask&Pipette | 3 | 2 | 1 | 6 | Y |
Autosampler Vial £¨more risk on impurity£© | 3 | 1 | 2 | 6 | Y |
Bottle & Baker | 1 | 1 | 2 | 2 | ¡¡ |
¡¡¡¡ÆäÖкìÉ«´ú±í¸ß·çÏÕ£¬£¬£¬»ÆÉ«´ú±íÖзçÏÕ£¬£¬£¬ÂÌÉ«´ú±íµÍ·çÏÕ¡£¡£¡£¡£¡£¡£
¡¡¡¡Æ¾Ö¤·çÏÕÆÀ¹ÀµÄЧ¹û¼°ÑéÖ¤µÄЧ¹û£¬£¬£¬È·¶¨ÆÊÎöÒªÁì×ªÒÆÑéÖ¤µÄ·½°¸£¬£¬£¬Ê¹·½°¸¸ü¿ÆÑ§¡¢ºÏÀí¡£¡£¡£¡£¡£¡£
¡¡¡¡Ð¤°ØÃ÷²©Ê¿¶Ô¸Ã´Î½²×ù¾ÙÐÐÁ˸üÉîÌõÀíµÄµãÆÀºÍÔö²¹£¬£¬£¬Í¬Ê±ÒÔÏîÄ¿ÖеÄʵÀý¾ÙÐÐÁËÔÙ´ÎÇ¿»¯Àο¿£¬£¬£¬Ê¹Í¬ÊÂÃǶԻ¯Ñ§Ò©ÎïÑз¢ÊÂÇéÓÐÁ˸üÉî¿ÌµÄÃ÷È·¡£¡£¡£¡£¡£¡£
¡¡¡¡½²×ùÒ»Á¬ÁË9¸öСʱ×óÓÒ£¬£¬£¬Í¨¹ý´Ë´ÎÅàѵ£¬£¬£¬UÀÖ¹ú¼ÊÒ½Ò©µÄͬÊÂÃÇÊÜÒæ·Ëdz£¬£¬£¬ÏÈÉúÃÇ´øÀ´µÄÏȽøµÄÑз¢Í·ÄÔ£¬£¬£¬¿ªÍØÁ˸÷È˵ÄÑз¢ÊÓÒ°¡£¡£¡£¡£¡£¡£Á½Î»ÏÈÉúÒ²±í´ïÁ˶Ը÷ÈËѧϰ̬¶È¼°Æð¾¢ÐÔµÄÈϿɣ¬£¬£¬ÏàÐÅÔÚÒÔºóµÄÒ©ÎïÑз¢ÊÂÇéÖпÉÒÔѧÒÔÖÂÓ㬣¬£¬Îª¹«Ë¾ÅÎȽ¡µÄÉú³¤×ö³öТ˳¡£¡£¡£¡£¡£¡£
ÉÏÒ»Ò³
ÏÂÒ»Ò³
ÉÏÒ»Ò³
ÏÂÒ»Ò³